Hannah Brendan
CIK 0001929422
Chief Business Officer and COO
Filings
12
Latest Jan 23, 2026
Issuers covered
1
Showing
12 of 12
Page 1
Track record
6 of 7 open-market trades scored (86% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 100% | +29.2% | +29.9% | +35.2% | +20.5% |
| 90 days | 6 | 100% | +181.7% | +181.7% | +186.9% | +176.6% |
| 180 days | 6 | 100% | +125.7% | +125.7% | +131.1% | +120.3% |
| 365 days | 6 | 100% | +158.8% | +157.7% | +167.2% | +151.6% |
Issuers
Companies where Hannah Brendan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | 12 | Jan 23, 2026 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|